UnknownPhase 1NCT04689893
Application of 68Ga-DOTA-TATE and 68Ga-DOTA-JR11 PET/CT in the Diagnosis and Evaluation of TIO
Studying Oncogenic osteomalacia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Peking Union Medical College Hospital
- Principal Investigator
- Hongli Jing, MDPeking Union Medical College Hospital
- Intervention
- 68Ga-Dotatate(drug)
- Enrollment
- 50 target
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2020 – 2022
Study locations (1)
- Peking union medical college hospital, Beijing, Dongcheng, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04689893 on ClinicalTrials.govOther trials for Oncogenic osteomalacia
Additional recruiting or active studies for the same condition.